FDA Approved: SOLIFENACIN SUCCINATE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Solifenacin succinate from ScieGen Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Solifenacin succinate (solifenacin)

Snippet

SUPPL AP for SOLIFENACIN SUCCINATE (SOLIFENACIN SUCCINATE)